1887

Abstract

During three seasons of mumps outbreaks in the Netherlands (September 2009–August 2012), 822 mumps cases were laboratory-confirmed at the National Institute for Public Health and the Environment (RIVM). Most patients were vaccinated young adults. Given the protracted endemic circulation, we studied the genetic diversity and changes of mumps virus over a period of 3 years. Phylogenetic analysis of the small hydrophobic (SH) gene (316 bp) was performed on a representative set of 808 specimens that tested positive for mumps via PCR. Additionally, the haemagglutinin/neuraminidase (HN) gene (1749 bp) and fusion (F) gene (1617 bp) were sequenced for a subset of samples ( = 17). Correlations between different sequence types and epidemiological and clinical data were investigated. The outbreaks in the Netherlands were dominated by two SH gene sequence types within genotype G, termed MuVs/Delft.NLD/03.10 (variant 1) and MuVs/Scheemda.NLD/12.10 (variant 2). Sequence analysis of the HN and F genes indicated that the outbreaks were initiated by separately introduced genetic lineages. The predominance of variant 2 by the end of the first outbreak season could not be explained by any of the epidemiological factors investigated. Orchitis was more frequently reported in males infected with variant 2, irrespective of age and vaccination status. These findings illustrate genetic heterogeneity of an emerging mumps genotype, and raise questions about the mechanisms driving mumps epidemiology and immunity in relation to vaccination.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.062943-0
2014-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/5/1074.html?itemId=/content/journal/jgv/10.1099/vir.0.062943-0&mimeType=html&fmt=ahah

References

  1. Barskey A. E., Schulte C., Rosen J. B., Handschur E. F., Rausch-Phung E., Doll M. K., Cummings K. P., Alleyne E. O., High P.other authors 2012; Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 367:1704–1713 [View Article][PubMed]
    [Google Scholar]
  2. Brockhoff H. J., Mollema L., Sonder G. J., Postema C. A., van Binnendijk R. S., Kohl R. H., de Melker H. E., Hahné S. J. 2010; Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 28:2932–2936 [View Article][PubMed]
    [Google Scholar]
  3. Carr M. J., Moss E., Waters A., Dean J., Jin L., Coughlan S., Connell J., Hall W. W., Hassan J. 2010; Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol 48:3288–3294 [View Article][PubMed]
    [Google Scholar]
  4. Cui A., Myers R., Xu W., Jin L. 2009; Analysis of the genetic variability of the mumps SH gene in viruses circulating in the UK between 1996 and 2005. Infect Genet Evol 9:71–80 [View Article][PubMed]
    [Google Scholar]
  5. Dayan G. H., Rubin S. 2008; Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis 47:1458–1467 [View Article][PubMed]
    [Google Scholar]
  6. Greenland K., Whelan J., Fanoy E., Borgert M., Hulshof K., Yap K. B., Swaan C., Donker T., van Binnendijk R.other authors 2012; Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine 30:4676–4680 [View Article][PubMed]
    [Google Scholar]
  7. Kontio M., Jokinen S., Paunio M., Peltola H., Davidkin I. 2012; Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 206:1542–1548 [View Article][PubMed]
    [Google Scholar]
  8. Kulkarni-Kale U., Ojha J., Manjari G. S., Deobagkar D. D., Mallya A. D., Dhere R. M., Kapre S. V. 2007; Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 359:436–446 [View Article][PubMed]
    [Google Scholar]
  9. Lim C. S., Chan K. P., Goh K. T., Chow V. T. 2003; Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J Med Virol 70:287–292 [View Article][PubMed]
    [Google Scholar]
  10. Malik T., Wolbert C., Mauldin J., Sauder C., Carbone K. M., Rubin S. A. 2007; Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. J Gen Virol 88:2533–2541 [View Article][PubMed]
    [Google Scholar]
  11. Malik T. H., Wolbert C., Nerret L., Sauder C., Rubin S. 2009; Single amino acid changes in the mumps virus haemagglutinin-neuraminidase and polymerase proteins are associated with neuroattenuation. J Gen Virol 90:1741–1747 [View Article][PubMed]
    [Google Scholar]
  12. Marin M., Quinlisk P., Shimabukuro T., Sawhney C., Brown C., Lebaron C. W. 2008; Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students – Iowa, 2006. Vaccine 26:3601–3607 [View Article][PubMed]
    [Google Scholar]
  13. Orvell C. 1984; The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol 132:2622–2629[PubMed]
    [Google Scholar]
  14. Rubin S. A., Amexis G., Pletnikov M., Li Z., Vanderzanden J., Mauldin J., Sauder C., Malik T., Chumakov K., Carbone K. M. 2003; Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 77:11616–11624 [View Article][PubMed]
    [Google Scholar]
  15. Rubin S. A., Qi L., Audet S. A., Sullivan B., Carbone K. M., Bellini W. J., Rota P. A., Sirota L., Beeler J. 2008; Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 198:508–515 [View Article][PubMed]
    [Google Scholar]
  16. Sane J., Gouma S., Koopmans M., de Melker H., Swaan C., van Binnendijk R., Hahne S. 2014; Epidemic of mumps among vaccinated persons, the Netherlands, 2009–2012. Emerg Infect Dis 20:643–648 [View Article]
    [Google Scholar]
  17. Santak M., Lang-Balija M., Ivancic-Jelecki J., Kosutic-Gulija T., Ljubin-Sternak S., Forcic D. 2012; Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol Infect 141:1298–1309 [View Article][PubMed]
    [Google Scholar]
  18. Takeuchi K., Tanabayashi K., Hishiyama M., Yamada A. 1996; The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156–162 [View Article][PubMed]
    [Google Scholar]
  19. Tecle T., Johansson B., Yun Z., Orvell C. 2000; Antigenic and genetic characterization of the fusion (F) protein of mumps virus strains. Arch Virol 145:1199–1210 [View Article][PubMed]
    [Google Scholar]
  20. Whelan J., van Binnendijk R., Greenland K., Fanoy E., Khargi M., Yap K., Boot H., Veltman N., Swaan C.other authors 2010; Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 15:19554[PubMed]
    [Google Scholar]
  21. WHO 2007; Mumps virus vaccines. Wkly Epidemiol Rec 82:51–60[PubMed]
    [Google Scholar]
  22. WHO 2012; Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec 87:217–224[PubMed]
    [Google Scholar]
  23. Wielders C. C., van Binnendijk R. S., Snijders B. E., Tipples G. A., Cremer J., Fanoy E., Dolman S., Ruijs Wl., Boot H. J.other authors 2011; Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill 16:19989[PubMed]
    [Google Scholar]
  24. Wilson R. L., Fuentes S. M., Wang P., Taddeo E. C., Klatt A., Henderson A. J., He B. 2006; Function of small hydrophobic proteins of paramyxovirus. J Virol 80:1700–1709 [View Article][PubMed]
    [Google Scholar]
  25. Xu P., Li Z., Sun D., Lin Y., Wu J., Rota P. A., He B. 2011; Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417:126–136 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.062943-0
Loading
/content/journal/jgv/10.1099/vir.0.062943-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error